Reporter Sept 23 2022

Diagnostic biomarker for bone disorder

Sep. 27, 2022—A urine chemical performs better as a diagnostic biomarker for the soft bone disease hypophosphatasia than other laboratory measures, Vanderbilt researchers have demonstrated.

Gender differences with bladder pain

Sep. 26, 2022—Gender differences in the pain experiences and treatment needs of people with a urologic pain syndrome could be used to improve interventions, Vanderbilt researchers report.

Vanderbilt University School of Medicine student Daniel Ragheb, second from left, with the classmates who helped save him — Joel Johnson, left, Brian Hou and Shreyas Krishnapura. (Not pictured: Yash Pershad).

Medical student’s life saved by quick action of classmates

Sep. 22, 2022—Daniel Ragheb's Vanderbilt University School of Medicine classmates came to his rescue after Ragheb experienced sudden cardiac arrest while the group was playing basketball.

Kaydi Naylor, 4, touches an eastern chain kingsnake at last week’s “MEGAMicrobe Express” community science fair at the Warner Elementary Arts Magnet School in East Nashville.

MEGAMicrobe event shows children that science can be fun

Sep. 22, 2022—More than 100 children who attended the “MEGAMicrobe Express” community science fair on Sept. 17 at the Warner Elementary Arts Magnet School in East Nashville.

Benoit Dawant, PhD, left, Erik Tkaczyk, MD, PhD, and colleagues have developed a new way to measure human monkeypox severity.

Vanderbilt study uses AI to speed monkeypox drug trials

Sep. 22, 2022—A machine learning algorithm developed by researchers at Vanderbilt performs as well as humans at identifying skin lesions in clinical photographs of people with monkeypox.

The International Retinal Research Foundation Board’s Sandra Blackwood poses with Vanderbilt’s Paul Sternberg Jr., MD, left, and David Calkins, PhD.

Major commitment bolsters Vanderbilt’s retinal vision research efforts

Sep. 22, 2022—A $10 million gift from the International Retinal Research Foundation will establish a center dedicated to retinal vision research at the Vanderbilt Eye Institute and a directorship to support a physician-scientist leader in the Department of Ophthalmology and Visual Sciences.

VUMC to lead AI ethics core for NIH project

Sep. 22, 2022—Vanderbilt researchers will lead and comprise the greater part of an artificial intelligence research ethics core for a National Institutes of Health (NIH) program called Bridge to Artificial Intelligence, or Bridge2AI.

Self named co-principal investigator of Vanderbilt’s Clinical and Translational Science Award

Sep. 22, 2022—Wesley Self, MD, MPH, a physician-scientist at Vanderbilt University Medical Center, has been named co-principal investigator (co-PI) of Vanderbilt’s Clinical and Translational Science Award (CTSA).

Medical laboratory scientist Gladys Garrison, MT, MS, loads reagents to prepare DNA samples for analysis in the VUMC Molecular Diagnostics Lab.

Nominations sought for Research Staff Awards

Sep. 22, 2022—Nominations for the 2022 Vanderbilt University School of Medicine Research Staff Awards are now being accepted.

Multisite project seeks to use patients’ voices to help diagnose disease

Sep. 22, 2022—Vanderbilt University Medical Center is partnering with 11 institutions on a $14 million NIH-funded project that aims to establish voice as a biomarker used in clinical care.

Policy experts discuss abortion ruling and health data privacy

Sep. 22, 2022—Vanderbilt policy experts discuss how the recent U.S. Supreme Court decision overturning Roe v. Wade and newly enacted state laws limiting or banning abortion can be expected to bring new scrutiny to the privacy vulnerabilities of electronic health records.

Reduced exercise capacity in ICU survivors

Sep. 22, 2022—ICU survivors who have impaired exercise capacity months after discharge may have damaged muscle mitochondria — the energy powerhouses of the cell, Vanderbilt researchers propose.